Clinical Trial Update: A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 study of KHK4083 in atopic dermatitis has completed. The update provides the status but does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• KHK4083

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED